Frederick Health-James M Stockman Cancer Institute

Frederick, Maryland 21702

0 studies enrolling now · 3 studies all time

What they study most

KEAP1 Gene Mutation, Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion, NFE2L2 Gene Mutation, NRF2 Gene Mutation, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung, Non-small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer

Studies at this site

• Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body — Recruiting now
• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early